KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Equity Ratio (2016 - 2026)

Quest Diagnostics' Equity Ratio history spans 18 years, with the latest figure at 0.46 for Q1 2026.

  • On a quarterly basis, Equity Ratio rose 4.33% to 0.46 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.46, a 4.33% increase, with the full-year FY2025 number at 0.44, up 4.77% from a year prior.
  • Equity Ratio hit 0.46 in Q1 2026 for Quest Diagnostics, up from 0.44 in the prior quarter.
  • Over the last five years, Equity Ratio for DGX hit a ceiling of 0.48 in Q2 2022 and a floor of 0.42 in Q4 2024.
  • Historically, Equity Ratio has averaged 0.46 across 5 years, with a median of 0.46 in 2022.
  • Biggest five-year swings in Equity Ratio: fell 11.34% in 2024 and later grew 5.43% in 2025.
  • Tracing DGX's Equity Ratio over 5 years: stood at 0.46 in 2022, then decreased by 2.09% to 0.45 in 2023, then dropped by 6.75% to 0.42 in 2024, then grew by 4.77% to 0.44 in 2025, then rose by 4.04% to 0.46 in 2026.
  • Business Quant data shows Equity Ratio for DGX at 0.46 in Q1 2026, 0.44 in Q4 2025, and 0.45 in Q3 2025.